Whalegun
Home

Neurocrine Biosciences NBIX paid Tarplin, Downs & Young $110K for lobbying in Q2 2026 · Health Issues, Medicare and 1 more issue

Trade details

Type
Lobbying report
Amount
$110,000
Quarter
Q2 2026
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
26/07/20

Up 37.5% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Neurocrine Biosciences's other lobbying reports